D. E. Shaw & Co., Inc. Pliant Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $112,983 - $166,699	10,679 New	10,679 $114,000
Q3 2023 Nov 14, 2023	SELL	$14.58 - $20.15 $5.39 Million - $7.45 Million	-369,664 Reduced 88.3%	48,999 $849,000
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $1.12 Million - $1.89 Million	-61,846 Reduced 12.87%	418,663 $7.59 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $5 Million - $9.67 Million	266,708 Added 124.75%	480,509 $12.8 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $25,738 - $38,501	-1,514 Reduced 0.7%	213,801 $4.13 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $1.1 Million - $3.47 Million	143,260 Added 198.82%	215,315 $4.5 Million
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $74,201 - $157,972	-18,054 Reduced 20.04%	72,055 $577,000
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $284,283 - $571,811	40,554 Added 81.84%	90,109 $632,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.26 $324,406 - $482,776	-26,439 Reduced 34.79%	49,555 $669,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $226,220 - $397,808	-13,727 Reduced 15.3%	75,994 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $375,140 - $504,066	13,374 Added 17.52%	89,721 $2.61 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $1.87 Million - $3.07 Million	76,347 New	76,347 $3 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.